Catalyst Pharmaceuticals
Data Breaches, Cyber Attacks and Security Report

https://catalystpharma.com  ᛫ 
Last updated December 14, 2019

About Catalyst Pharmaceuticals

Company Overview

Catalyst Pharmaceuticals is a biopharmaceutical company based in Coral Gables, Florida. The company is developing therapeutics for rare neurological diseases, including the phosphate salt of amifampridine for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) under the trade name "Firdapse", and CPP-115 (a GABA transaminase) for the treatment of infantile spasms.

Valuation

Employees

CEO

Location

Data Breaches and Security News

Catalyst Pharmaceuticals Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Catalyst Pharmaceuticals is implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Catalyst Pharmaceuticals

Get full security report ›

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Catalyst Pharmaceuticals's security performance with other companies